ALNY

#288
Alnylam Pharmaceuticals, Inc.
332.92
+0.42%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
332.77
332.92
Intervallo Annuale
205.87
495.55
Variazione giornaliera
+0.42%
Variazione Mensile
-5.86%
Variazione di 6 mesi
-26.35%
Variazione Annuale
+40.72%
Chiusura Precedente
331.54
Open
332.77
Bid
Ask
Low
332.77
High
332.92
Volume
379
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

Notizie